A Study of Chemotherapy and Radiation Therapy Compared to Chemotherapy and Radiation Therapy Plus MEDI4736 (Durvalumab) Immunotherapy for Bladder Cancer Which Has Spread to the Lymph Nodes, the INSPIRE Study
Conditions: Bladder Urothelial Carcinoma; Stage III Bladder Cancer AJCC v8; Stage IIIA Bladder Cancer AJCC v8; Stage IIIB Bladder Cancer AJCC v8 Interventions: Drug: Carboplatin; Drug: Cisplatin; Drug: Doxorubicin; Drug: Doxorubicin Hydrochloride; Biological: Durvalumab; Drug: Fluorouracil; Drug: Gemcitabine; Drug: Gemcitabine Hydrochloride; Drug: Methotrexate; Drug: Mitomycin; Other: Patient Observation; Radiation: Radiation Therapy; Drug: Vinblastine; Drug: Vinblastine Sulfate Sponsor: National Cancer Institute (NCI) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Bladder Cancer | Cancer | Cancer & Oncology | Carcinoma | Chemotherapy | Immunotherapy | Methotrexate | Radiation Therapy | Research | Study